A provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, academic research, environmental testing and general industrial markets, commonly referred to as the health sciences and photonics markets.


Updates from The Motley Fool

Latest updates on PerkinElmer from Fool.com.
What to Expect from PerkinElmer

PerkinElmer ( NYSE: PKI     ) is expected to report Q2 earnings on Aug. 1. Here's what Wall St...

Golf Clap for PerkinElmer

PerkinElmer ( NYSE: PKI     ) reported earnings on Jan. 31. Here are the numbers you need to k...

PerkinElmer Passes This Key Test

There's no foolproof way to know the future for PerkinElmer ( NYSE: PKI     ) or any other co...

Why PerkinElmer Shares Jumped

Although we don't believe in timing the market or panicking over market movements, we do like to ...

PerkinElmer Passes This Key Test

There's no foolproof way to know the future for PerkinElmer ( NYSE: PKI     ) or any other co...

PerkinElmer Passes This Key Test

There's no foolproof way to know the future for PerkinElmer ( NYSE: PKI     ) or any other co...

PerkinElmer Passes This Key Test

There's no foolproof way to know the future for PerkinElmer ( NYSE: PKI     ) or any other co...



Stock Performance

View Interactive PKI Charts
Sponsored by

Key Data Points

Primary metrics and data points about PerkinElmer.
Current Price: $52.52
Prev Close: $52.10
Open: $52.00
Bid: $52.48
Ask: $52.49
Day's Range: $51.88 - $52.52
52wk Range: $39.50 - $57.28
Volume: 553,997
Avg Vol 727,091
Market Cap: $6B
P/E (ttm): 24.58
EPS (ttm): $2.12
Div & Yield: $0.28 (0.5%)

Company Rating

What our community thinks about PerkinElmer.
CAPS Rating 2 out of 5
 
106 Outperform
13 Underperform
CAPS All Stars
 
31 Outperform
3 Underperform

How do you think PerkinElmer will perform against the market?



You pick for PerkinElmer is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Rob Friel, CEO

56% Approve

Based on 125 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for PerkinElmer.

A provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, academic research, environmental testing and general industrial markets, commonly referred to as the health sciences and photonics markets.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Healthcare IT